| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.2M | -54.7% |
| SG&A Expense | $5.7M | -19.9% |
| Operating Income | -$12.9M | +59.5% |
| Net Income | -$12.5M | +60.3% |
| EPS (Basic) | -$3.84 | +74.2% |
| EPS (Diluted) | -$3.84 | +74.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | -51.3% |
| Current Assets | $6.5M | -55.1% |
| Total Assets | $6.6M | -55.0% |
| Total Liabilities | $1.3M | -69.5% |
| Stockholders' Equity | $5.3M | -49.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.8M | +27.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $6.6M | +234.1% |